Vortioxetine is a multimodal antidepressant with serotonergic activity that acts as a serotonin receptor modulator, potentially influencing neurotransmitter systems involved in pain perception and neurogenic inflammation. While primarily indicated for depression, its mechanism of action suggests potential off-label utility in managing cluster headache by modulating serotonergic pathways and potentially reducing neurogenic inflammation associated with headache pathogenesis.